1.Cystic Nephroma: A Case Report and Comparing Literature Review with Mixed Epithelial and Stromal Tumor of Kidney.
Hyun Jung KIM ; Choong Hee NOH ; Giyoung KWON ; Eunah SHIN ; Jung Yeon KIM ; Kyeongmee PARK
Korean Journal of Pathology 2011;45(Suppl 1):S25-S28
Cystic nephroma (CN) is a benign cystic neoplasm composed of mixed epithelial and stromal elements. Less than 200 cases have been reported. We had a patient, a 41-year-old woman, who had a huge typical CN. The patient was admitted for a right renal mass that was found incidentally. On laparaoscopic right nephrectomy, there was an encapsulated 7 cm multilocular cystic mass at the upper pole. Microscopically, the cystic wall was lined by a single layer of low cuboidal or hobnail epithelium without a solid area. The thin septa were composed of bland, ovarian type spindle cells. The main differential diagnoses were mixed epithelial and stromal tumor (MEST), low grade multilocular renal cell carcinoma, and tubulocystic carcinoma. The results of immunohistochemical staining were cytokeratin 7/19(+/+) and CD10(-) in lining epithelium, estrogen receptor/progesterone receptor(+/+) in stromal cells. After surgery, she was free of recurrence for 10 months. We report this rare case and compare it with other cystic renal tumors, especially MEST.
Adult
;
Carcinoma, Renal Cell
;
Diagnosis, Differential
;
Epithelium
;
Estrogens
;
Female
;
Humans
;
Keratins
;
Kidney
;
Nephrectomy
;
Receptors, Estrogen
;
Recurrence
;
Stromal Cells
2.Effect of genistein administration on the recovery of spermatogenesis in the busulfan-treated rat testis.
Heejun CHI ; Kangwoo CHUN ; Hyukjun SON ; Jonghyun KIM ; Giyoung KIM ; Sungil ROH
Clinical and Experimental Reproductive Medicine 2013;40(2):60-66
OBJECTIVE: Impairment of spermatogenesis has been identified as an inevitable side effect of cancer treatment. Although estrogen treatment stimulates spermatogenic recovery from the impaired spermatogenesis by suppressing the intra-testicular testosterone (ITT) level, side effects of estrogen are still major impediments to its clinical application in humans. Soybeans are rich in genistein, which is a phytoestrogen that binds to estrogen receptors and has an estrogenic effect. We investigated the effects of genistein administration on ITT levels, testis weight, and recovery of spermatogenesis in rats treated with a chemotherapeutic agent, busulfan. METHODS: Busulfan was administered intraperitoneally to rats, and then a GnRH agonist was injected subcutaneously into the back, or genistein was administered orally. RESULTS: The weight of the testes was significantly reduced by the treatment with busulfan. The testis weight was partially restored after busulfan treatment by additional treatment with either the GnRH agonist or genistein. Busulfan also induced atrophy of a high percentage of the seminiferous tubules, but this percentage was decreased by additional treatment with either the GnRH agonist or genistein. Treatment with genistein was effective at suppressing and maintaining ITT levels comparable to that in the GnRH agonist group. CONCLUSION: Genistein effectively suppressed ITT levels and stimulated the recovery of spermatogenesis in rats treated with a chemotherapeutic drug. This suggests that genistein may be a substitute for estrogens, for helping humans to recover fertility after cancer therapy without the risk of side effects.
Animals
;
Atrophy
;
Busulfan
;
Estrogens
;
Fertility
;
Genistein
;
Gonadotropin-Releasing Hormone
;
Humans
;
Phytoestrogens
;
Rats
;
Receptors, Estrogen
;
Seminiferous Tubules
;
Soybeans
;
Spermatogenesis
;
Testis
;
Testosterone
3.Successful systemic thrombolysis of both the inferior vena cava and a renal vein thrombi that complicated nephrotic syndrome.
Hyung Seok LEE ; Jin Taek KIM ; Joo Won MIN ; Giyoung KWON ; Bong Soo KIM ; Guk Myung CHOI ; Woo Heon KANG
Korean Journal of Medicine 2007;73(4):448-452
Nephrotic syndrome has been considered a hypercoagulable state because thromboembolic events of the venous or the arterial circulations occur on occasion. There are various risk factors for thromboembolism in patients with nephrotic syndrome (membranous nephropathy, severe hypoalbuminemia, hemoconcentration and medications such as steroid and diuretics). As thromboembolism is often fatal, early detection and proper management are important. Although anticoagulation is the preferred therapy, thrombolysis may be considered for an extensive thrombosis, for inferior vena cava (IVC) thrombosis, for recurrent pulmonary thromboembolism and for bilateral renal vein thrombosis in conjunction with acute renal failure. We report here on a case of renal vein and IVC thrombosis in a 24-year-old male with nephrotic syndrome, and this patient was treated with intravenous thrombolytics rather than anticoagulation and local thrombolytic infusion. He complained of left flank pain and his CT scan revealed left renal vein thrombosis and IVC thrombosis. After urokinase infusion, his thrombi were resolved successfully without bleeding complications.
Acute Kidney Injury
;
Flank Pain
;
Hemorrhage
;
Humans
;
Hypoalbuminemia
;
Male
;
Nephrotic Syndrome*
;
Pulmonary Embolism
;
Renal Veins*
;
Risk Factors
;
Thromboembolism
;
Thrombosis
;
Tomography, X-Ray Computed
;
Urokinase-Type Plasminogen Activator
;
Vena Cava, Inferior*
;
Young Adult